Vaughan Nelson Investment Management’s Merck MRK Stock Holding History

Vaughan Nelson Investment Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.41M	Hold	18,735	–	–	0.02%	158
2026 Q1	$2.25M	Hold	18,735	–	–	0.02%	157
2025 Q4	$1.97M	Sell	18,735 -11,515	-38%	-$1.08M	0.02%	159
2025 Q3	$2.54M	Hold	30,250	–	–	0.02%	158
2025 Q2	$2.39M	Hold	30,250	–	–	0.02%	152
2025 Q1	$2.71M	Hold	30,250	–	–	0.03%	157
2024 Q4	$3.01M	Hold	30,250	–	–	0.03%	149
2024 Q3	$3.44M	Buy	30,250 +75	+0.2%	+$8.91K	0.03%	144
2024 Q2	$3.74M	Hold	30,175	–	–	0.03%	144
2024 Q1	$3.98M	Sell	30,175 -40	-0.1%	-$4.93K	0.03%	144
2023 Q4	$3.29M	Sell	30,215 -3,360	-10%	-$349K	0.03%	156
2023 Q3	$3.46M	Buy	33,575 +225	+0.7%	+$24.3K	0.04%	166
2023 Q2	$3.85M	Sell	33,350 -2,850	-8%	-$324K	0.04%	158
2023 Q1	$3.85M	Sell	36,200 -15,000	-29%	-$1.62M	0.05%	146
2022 Q4	$5.68M	Buy	51,200 +1,100	+2%	+$112K	0.07%	149
2022 Q3	$4.32M	Hold	50,100	–	–	0.06%	141
2022 Q2	$4.57M	Hold	50,100	–	–	0.06%	146
2022 Q1	$4.11M	Buy	50,100 +8,075	+19%	+$637K	0.05%	153
2021 Q4	$3.22M	Hold	42,025	–	–	0.03%	156
2021 Q3	$3.16M	Buy	42,025 +4,850	+13%	+$369K	0.03%	153
2021 Q2	$2.89M	Buy	37,175 +1,805	+5%	+$134K	0.03%	153
2021 Q1	$2.6M	Buy	35,370 +4,899	+16%	+$361K	0.03%	144
2020 Q4	$2.38M	Buy	30,471 +12,341	+68%	+$944K	0.03%	146
2020 Q3	$1.44M	Hold	18,130	–	–	0.02%	159
2020 Q2	$1.34M	Hold	18,130	–	–	0.02%	172
2020 Q1	$1.33M	Hold	18,130	–	–	0.02%	175
2019 Q4	$1.57M	Sell	18,130 -6,288	-26%	-$516K	0.02%	162
2019 Q3	$1.96M	Hold	24,418	–	–	0.03%	156
2019 Q2	$1.95M	Hold	24,418	–	–	0.03%	164
2019 Q1	$1.94M	Hold	24,418	–	–	0.03%	165
2018 Q4	$1.78M	Hold	24,418	–	–	0.03%	168
2018 Q3	$1.65M	Hold	24,418	–	–	0.02%	174
2018 Q2	$1.41M	Hold	24,418	–	–	0.02%	172
2018 Q1	$1.27M	Hold	24,418	–	–	0.02%	176
2017 Q4	$1.31M	Buy	24,418 +7,440	+44%	+$412K	0.02%	181
2017 Q3	$1.04M	Hold	16,978	–	–	0.01%	193
2017 Q2	$1.04M	Hold	16,978	–	–	0.01%	187
2017 Q1	$1.03M	Hold	16,978	–	–	0.01%	172
2016 Q4	$954K	Hold	16,978	–	–	0.01%	170
2016 Q3	$1.01M	Sell	16,978 -6,602	-28%	-$386K	0.01%	168
2016 Q2	$1.3M	Hold	23,580	–	–	0.02%	164
2016 Q1	$1.19M	Hold	23,580	–	–	0.02%	163
2015 Q4	$1.19M	Sell	23,580 -14	-0.1%	-$706	0.02%	156
2015 Q3	$1.11M	Buy	23,594 +14	+0.1%	+$744	0.02%	153
2015 Q2	$1.28M	Hold	23,580	–	–	0.02%	144
2015 Q1	$1.29M	Hold	23,580	–	–	0.02%	145
2014 Q4	$1.28M	Hold	23,580	–	–	0.02%	150
2014 Q3	$1.33M	Hold	23,580	–	–	0.02%	154
2014 Q2	$1.3M	Hold	23,580	–	–	0.02%	163
2014 Q1	$1.28M	Hold	23,580	–	–	0.02%	162
2013 Q4	$1.13M	Hold	23,580	–	–	0.02%	163
2013 Q3	$1.07M	Buy	23,580 +5,397	+30%	+$246K	0.02%	168
2013 Q2	$806K	Buy	+18,183	New	+$812K	0.02%	166

Other funds holding MRK

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Vaughan Nelson Investment Management's MRK Position: Q2 2026 in Review

Vaughan Nelson Investment Management held its Merck (MRK) position steady in Q2 2026 at 18,735 shares worth $2.41M. The position accounts for 0.02% of the portfolio, ranked #158.

Vaughan Nelson Investment Management first reported a position in MRK in Q2 2013 and has held it in 53 quarters since. The position peaked at $5.68M in Q4 2022. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Vaughan Nelson Investment Management held 18,735 shares of Merck worth $2.41M as of Q2 2026.
Vaughan Nelson Investment Management left its Merck share count unchanged in Q2 2026.
Merck made up 0.02% of Vaughan Nelson Investment Management's portfolio in Q2 2026, its #158 holding.
Vaughan Nelson Investment Management first reported a position in Merck in Q2 2013 and has held it in 53 quarters since.
Vaughan Nelson Investment Management's Merck position peaked at $5.68M in Q4 2022.
1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Vaughan Nelson Investment Management's 13F filing for Q2 2026, filed 16 Jul 2026.